Relative versus attributable risk of breast cancer from estrogen replacement therapy
J Clin Endocrinol Metab
.
1999 Jun;84(6):1875-81.
doi: 10.1210/jcem.84.6.5771.
Authors
R J Santen
1
,
G R Petroni
Affiliation
1
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
PMID:
10372679
DOI:
10.1210/jcem.84.6.5771
No abstract available
Publication types
Comparative Study
Review
MeSH terms
Aged
Breast Neoplasms / chemically induced*
Breast Neoplasms / epidemiology
Estrogen Replacement Therapy / adverse effects*
Female
Humans
Middle Aged
Risk Assessment